Woodline Partners’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,040,704
Closed -$1.9M 1105
2025
Q4
$1.9M Buy
1,040,704
+953
+0.1% +$1.91K 0.01% 775
2025
Q3
$2.47M Buy
+1,039,751
New +$3.15M 0.01% 697
2025
Q1
Sell
-245,676
Closed -$5.25M 970
2024
Q4
$5.25M Sell
245,676
-249,428
-50% -$5.19M 0.04% 478
2024
Q3
$9.31M Buy
495,104
+81,164
+20% +$1.62M 0.08% 310
2024
Q2
$9.4M Buy
413,940
+34,694
+9% +$832K 0.09% 255
2024
Q1
$11.1M Buy
379,246
+205,947
+119% +$3.66M 0.1% 247
2023
Q4
$1.37M Sell
173,299
-126,701
-42% -$850K 0.01% 394
2023
Q3
$2.1M Hold
300,000
0.02% 396
2023
Q2
$4.11M Hold
300,000
0.05% 322
2023
Q1
$5.43M Buy
+300,000
New +$5.55M 0.08% 285

Other funds holding JSPR